Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Ismaila (Cary, United States of America). Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data. 2788

Member's Comments

No comment yet.

Related content which might interest you: Single inhaler triple therapy in patients with advanced COPD: healthcare resource utilisation and cost data from the FULFIL study Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Treatment patterns of COPD patients in France: A retrospective analysis of an administrative primary care healthcare database Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 The cost burden of COPD in France: A retrospective analysis of an administrative primary care database Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Cost-effectiveness of antibiotics for COPD management: observational analysis using CPRD data Source: ERJ Open Res, 3 (2) 00085-2016; 10.1183/23120541.00085-2016 Year: 2017 Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Comparison of dual vs triple therapies in patients hospitalized for COPD in France: a claims data study Source: International Congress 2018 – COPD management Year: 2018 Change in asthma management recommendations is associated with reduction of reliever drugs in the real-world setting: a longitudinal retrospective claims data analysis in Burgenland Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Step-down of non-indicated triple therapy in COPD using routine primary care data: A regional pilot study Source: International Congress 2018 – Primary care management of COPD Year: 2018 Persistence to COPD therapies and impact on exacerbations: a French claims data study Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Economic evaluation of the impact of exacerbation frequency in COPD patients treated with single-inhaler triple therapy in Spain: The IMPACT trial Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Identifying predictors of healthcare utilization and costs in COPD patients over 18 months: first longitudinal results of the COSYCONET cohort Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018 Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020 Year: 2021 Telemonitoring in outpatients with COPD: a retrospective analysis of the effect on exacerbation rate, hospital admission and overall healthcare consumption using myCOPDcoach Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020 Direct cost analysis of COPD patients: A 1 year follow-up study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 The primary care routine data registry BeoNet: First pilot phase results for COPD research Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015 Late Breaking Abstract - IMPACT study — single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: healthcare resource utilization and costs — UK Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018 Dispensed asthma therapy and medical resource utilisation in asthma patients: results from the L777 observational study Source: Annual Congress 2009 - Epidemiology of asthma Year: 2009 Estimating exacerbation rates from routine UK primary care data: an exploratory validation from the IMP2ART programme. Source: International Congress 2017 – Primary care management of asthma and COPD Year: 2017 Demographics, clinical characteristics, health resource utilization and cost of patients with CTEPH: Retrospective results from six European countries Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Costs of a methodology applied to the ambulatory follow up of patients with continuous asthma in a primary care practice. An observational study using an electronic record with data base linked by the internet Source: Eur Respir J 2006; 28: Suppl. 50, 209s Year: 2006